Opternative, a Chicago-based purveyor of online and mobile refractive eye exams, received a warning letter from the FDA last fall. The October 30 warning letter was only recently made public by the agency.
Addressed to then-CEO Aaron Dallek (Opternative named a new CEO, Brent Rasmussen, in January), the letter makes it clear that it considers Opternative's online eye exam to be a mobile medical...
